CAS RN: 2045189-35-1
3-Fluoroazetidine-1-ethanamine
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250402
100mg / 500mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g, 0.25g, 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2045189-35-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
≥95%
0
Out of Stock
Shanghai
Inquiry
0.25g
≥95%
0
Out of Stock
Shenzhen
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
2045189-35-1 / 2-(3-fluoroazetidin-1-yl)ethanamine
Standard CAS: 2045189-35-1
Multi CAS: No
Basic Information
copy
CAS
2045189-35-1 copy
Multi CAS
No copy
Molecular Formula
C5H11FN2 copy
Molecular Weight
118.150000 copy
Exact Mass
118.090627 copy
SMILES
C1C(CN1CCN)F copy
InChI
InChI=1S/C5H11FN2/c6-5-3-8(4-5)2-1-7/h5H,1-4,7H2 copy
InChIKey
ZVOBAJVTRLDBGM-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
8 copy
Fraction Csp3
1 copy
Rotatable bonds
2 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
30.39 copy
TPSA
29.26 copy
LogP / Solubility
WLOGP
-0.4 copy
MLOGP
-0.36 copy
XLogP3
-0.5 copy
Consensus LogP
-0.42 copy
Log S (ESOL)
-0.19 copy
Class (ESOL)
Very soluble copy
Log S (Ali)
-0.24 copy
Class (Ali)
Very soluble copy
Log S (SILICOS-IT)
-0.34 copy
Class (SILICOS-IT)
Very soluble copy
ADME
GI absorption
Low copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.73 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy